Jonathan M. Davison
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jonathan M. Davison has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Jess A Graham
Department of Radiology, Madigan Army Medical Center, Tacoma, Washington, USA
2 shared publicationsAaron L. Stack
1 shared publicationAnthony J Fadell
Medicine Department, Madigan Army Medical Center, Tacoma, Washington, USA
1 shared publicationDerek J. Stocker
1 shared publicationJaime L. Montilla-Soler
1 shared publicationJennifer S. Jurgens
1 shared publication
Latest Publications
- Open Access
- 23 January 2013
- Published by BMJ in BMJ Case Reports
- Vol. 2013
PET-CT confirms the diagnosis of pyogenic spondylodiscitis complicated by psoas abscess
- 23 January 2013
- Published by BMJ in BMJ Case Reports
- Vol. 2013
Open AccessPET-CT confirms the diagnosis of pyogenic spondylodiscitis complicated by psoas abscess
- Open Access
- 20 March 2012
- Published by BMJ in BMJ Case Reports
- Vol. 2012
PET-CT aids in the diagnosis of a choroidal mass with retinal detachment in a patient with history of breast cancer and sarcoidosis
- 20 March 2012
- Published by BMJ in BMJ Case Reports
- Vol. 2012
Open AccessPET-CT aids in the diagnosis of a choroidal mass with retinal detachment in a patient with history of breast cancer and sarcoidosis
- 1 July 2008
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 33 (7) , 464-468
The Added Benefit of a Dedicated Neck F-18 FDG PET-CT Imaging Protocol in Patients With Suspected Recurrent Differentiated Thyroid Carcinoma
To retrospectively analyze whether adding a delayed high-resolution dedicated neck F-18 FDG positron emission tomography-computerized tomographic (PET-CT) imaging protocol in patients with recurrent differentiated thyroid cancer increases the number of abnormal foci within the neck. Seventeen PET-CT studies from a total of 10 patients with suspected recurrent differentiated thyroid cancer between March 2003 and June 2004 were retrospectively reviewed. Each study included a whole body acquisition (WBA), followed by higher resolution dedicated neck acquisition (DNA). Two board-certified nuclear medicine physicians reviewed either the DNA or WBA for each study and recorded the number of abnormal foci, along with presence or absence of a soft tissue abnormality, and maximum standardized uptake value for each foci. Consensus review was used for all discrepancies. Statistical analysis was performed to determine whether there was a statistically significant increase in the number of studies demonstrating new abnormal foci with the addition of a DNA. Five of 17 studies demonstrated an increase in the number of abnormal foci with the addition of the DNA (P < 0.04). A total of 8 abnormal foci were noted on the WBA, 4 of which were within the neck. Eleven additional abnormal foci were seen on the DNA. All abnormal foci within the neck had corresponding soft tissue abnormalities except for one. Adding a higher resolution delayed DNA to the WBA for patients undergoing PET-CT imaging to detect recurrent thyroid cancer increases the number of abnormal sites of FDG accumulation.
- 1 July 2008
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 33 (7) , 464-468
The Added Benefit of a Dedicated Neck F-18 FDG PET-CT Imaging Protocol in Patients With Suspected Recurrent Differentiated Thyroid Carcinoma
To retrospectively analyze whether adding a delayed high-resolution dedicated neck F-18 FDG positron emission tomography-computerized tomographic (PET-CT) imaging protocol in patients with recurrent differentiated thyroid cancer increases the number of abnormal foci within the neck. Seventeen PET-CT studies from a total of 10 patients with suspected recurrent differentiated thyroid cancer between March 2003 and June 2004 were retrospectively reviewed. Each study included a whole body acquisition (WBA), followed by higher resolution dedicated neck acquisition (DNA). Two board-certified nuclear medicine physicians reviewed either the DNA or WBA for each study and recorded the number of abnormal foci, along with presence or absence of a soft tissue abnormality, and maximum standardized uptake value for each foci. Consensus review was used for all discrepancies. Statistical analysis was performed to determine whether there was a statistically significant increase in the number of studies demonstrating new abnormal foci with the addition of a DNA. Five of 17 studies demonstrated an increase in the number of abnormal foci with the addition of the DNA (P < 0.04). A total of 8 abnormal foci were noted on the WBA, 4 of which were within the neck. Eleven additional abnormal foci were seen on the DNA. All abnormal foci within the neck had corresponding soft tissue abnormalities except for one. Adding a higher resolution delayed DNA to the WBA for patients undergoing PET-CT imaging to detect recurrent thyroid cancer increases the number of abnormal sites of FDG accumulation.